Inger Wallin
Impact in
- Sensory Systems top 2%
- Hearing, Cochlea, Tinnitus, Genetics
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 19
- Drug Transport and Resistance Mechanisms 8
- Cancer Treatment and Pharmacology 7
- Metal complexes synthesis and properties 4
- Colorectal Cancer Treatments and Studies 3
-
- Hearing, Cochlea, Tinnitus, Genetics 7
- Co-authors
- Hans Ehrsson (43 shared papers)Staffan Eksborg (17 shared papers)Moustapha Hassan (4 shared papers)Göran Laurell (8 shared papers)Elin Jerremalm (4 shared papers)Jeffrey Yachnin (3 shared papers)Bengt Simonsson (5 shared papers)M. Ehrnebo (4 shared papers)
In The Last Decade
Inger Wallin
48 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 117
- Sensory Systems 202
- Hematology 279
- Oncology 468
- Pharmacology 95
- Transplantation 26
Countries citing papers authored by Inger Wallin
This map shows the geographic impact of Inger Wallin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Wallin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Wallin more than expected).
Fields of papers citing papers by Inger Wallin
This network shows the impact of papers produced by Inger Wallin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Wallin. The network helps show where Inger Wallin may publish in the future.
Co-authors
The 25 scholars most cited alongside Inger Wallin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 129 | |
| 2 | 1997 | 120 | |
| 3 | 1989 | 119 | |
| 4 | 1993 | 105 | |
| 5 | 2002 | 89 | |
| 6 | 2008 | 87 | |
| 7 | 1999 | 71 | |
| 8 | 2004 | 64 | |
| 9 | 2002 | 62 | |
| 10 | 2000 | 53 | |
| 11 | 1995 | 53 | |
| 12 | 2003 | 52 | |
| 13 | Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility. | 2004 | 50 |
| 14 | 2009 | 42 | |
| 15 | 2006 | 35 | |
| 16 | 1980 | 35 | |
| 17 | 1977 | 34 | |
| 18 | 2004 | 31 | |
| 19 | 2013 | 30 | |
| 20 | 2014 | 30 |
About Inger Wallin
Inger Wallin is a scholar working on Oncology, Sensory Systems, Pharmacology, Pharmacology and Hematology, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Hearing, Cochlea, Tinnitus, Genetics (7 papers), Cancer Treatment and Pharmacology (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Chemotherapy-induced organ toxicity mitigation (5 papers), Metal complexes synthesis and properties (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Sensory Systems (202 citations), Hematology (279 citations), Oncology (468 citations), Pharmacology (95 citations) and Transplantation (26 citations). Inger Wallin has collaborated with scholars based in Sweden, Germany and Denmark. Frequent co-authors include Hans Ehrsson, Staffan Eksborg, Moustapha Hassan, Göran Laurell, Elin Jerremalm, Jeffrey Yachnin, Bengt Simonsson, M. Ehrnebo, Göran Berg and B Smedmyr. Their work appears in journals such as European Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology, Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics and Acta Oto-Laryngologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.